174 related articles for article (PubMed ID: 27659012)
61. [DDP-sensitivity-related genes in 10 lung cancer cell lines].
Li CH; Cai L; Chen XS; Meng QW; Sui GJ
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):418-21. PubMed ID: 19024514
[TBL] [Abstract][Full Text] [Related]
62. Combined Use of Gene Expression Modeling and siRNA Screening Identifies Genes and Pathways Which Enhance the Activity of Cisplatin When Added at No Effect Levels to Non-Small Cell Lung Cancer Cells In Vitro.
Leung AW; Hung SS; Backstrom I; Ricaurte D; Kwok B; Poon S; McKinney S; Segovia R; Rawji J; Qadir MA; Aparicio S; Stirling PC; Steidl C; Bally MB
PLoS One; 2016; 11(3):e0150675. PubMed ID: 26938915
[TBL] [Abstract][Full Text] [Related]
63. ATF3 Repression of BCL-X
Chüeh AC; Tse JWT; Dickinson M; Ioannidis P; Jenkins L; Togel L; Tan B; Luk I; Davalos-Salas M; Nightingale R; Thompson MR; Williams BRG; Lessene G; Lee EF; Fairlie WD; Dhillon AS; Mariadason JM
Clin Cancer Res; 2017 Sep; 23(18):5573-5584. PubMed ID: 28611196
[No Abstract] [Full Text] [Related]
64. Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors.
Dalvi MP; Wang L; Zhong R; Kollipara RK; Park H; Bayo J; Yenerall P; Zhou Y; Timmons BC; Rodriguez-Canales J; Behrens C; Mino B; Villalobos P; Parra ER; Suraokar M; Pataer A; Swisher SG; Kalhor N; Bhanu NV; Garcia BA; Heymach JV; Coombes K; Xie Y; Girard L; Gazdar AF; Kittler R; Wistuba II; Minna JD; Martinez ED
Cell Rep; 2017 May; 19(8):1669-1684. PubMed ID: 28538184
[TBL] [Abstract][Full Text] [Related]
65. Inhibition of the hexosamine biosynthesis pathway potentiates cisplatin cytotoxicity by decreasing BiP expression in non-small-cell lung cancer cells.
Chen W; Do KC; Saxton B; Leng S; Filipczak P; Tessema M; Belinsky SA; Lin Y
Mol Carcinog; 2019 Jun; 58(6):1046-1055. PubMed ID: 30790354
[TBL] [Abstract][Full Text] [Related]
66. Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination.
St Germain C; O'Brien A; Dimitroulakos J
Cancer Cell Int; 2010 Sep; 10():32. PubMed ID: 20828393
[TBL] [Abstract][Full Text] [Related]
67. Activating Transcription Factor 3 as a Novel Regulator of Chemotherapy Response in Breast Cancer.
Hasim MS; Nessim C; Villeneuve PJ; Vanderhyden BC; Dimitroulakos J
Transl Oncol; 2018 Aug; 11(4):988-998. PubMed ID: 29940414
[TBL] [Abstract][Full Text] [Related]
68. ATF3 characterizes aggressive drug-tolerant persister cells in HGSOC.
Böpple K; Oren Y; Henry WS; Dong M; Weller S; Thiel J; Kleih M; Gaißler A; Zipperer D; Kopp HG; Aylon Y; Oren M; Essmann F; Liang C; Aulitzky WE
Cell Death Dis; 2024 Apr; 15(4):290. PubMed ID: 38658567
[TBL] [Abstract][Full Text] [Related]
69. Activating Transcription Factor 3 Expression as a Marker of Response to the Histone Deacetylase Inhibitor Pracinostat.
Sooraj D; Xu D; Cain JE; Gold DP; Williams BR
Mol Cancer Ther; 2016 Jul; 15(7):1726-39. PubMed ID: 27196751
[TBL] [Abstract][Full Text] [Related]
70. JMJD2 promotes acquired cisplatin resistance in non-small cell lung carcinoma cells.
Duan L; Perez RE; Chastain PD; Mathew MT; Bijukumar DR; Maki CG
Oncogene; 2019 Jul; 38(28):5643-5657. PubMed ID: 30967636
[TBL] [Abstract][Full Text] [Related]
71. Activation of the c-Jun N-terminal kinase/activating transcription factor 3 (ATF3) pathway characterizes effective arylated diazeniumdiolate-based nitric oxide-releasing anticancer prodrugs.
Maciag AE; Nandurdikar RS; Hong SY; Chakrapani H; Diwan B; Morris NL; Shami PJ; Shiao YH; Anderson LM; Keefer LK; Saavedra JE
J Med Chem; 2011 Nov; 54(22):7751-8. PubMed ID: 22003962
[TBL] [Abstract][Full Text] [Related]
72. Activating transcription factor 3 promotes malignance of lung cancer cells in vitro.
Li X; Zhou X; Li Y; Zu L; Pan H; Liu B; Shen W; Fan Y; Zhou Q
Thorac Cancer; 2017 May; 8(3):181-191. PubMed ID: 28239957
[TBL] [Abstract][Full Text] [Related]
73. Stress-inducible gene
Chang YS; Jalgaonkar SP; Middleton JD; Hai T
Proc Natl Acad Sci U S A; 2017 Aug; 114(34):E7159-E7168. PubMed ID: 28784776
[TBL] [Abstract][Full Text] [Related]
74. Regorafenib induces NOX5-mediated endoplasmic reticulum stress and potentiates the anti-tumor activity of cisplatin in non-small cell lung cancer cells.
Sui H; Xiao S; Jiang S; Wu S; Lin H; Cheng L; Ye L; Zhao Q; Yu Y; Tao L; Kong FM; Huang X; Cui R
Neoplasia; 2023 May; 39():100897. PubMed ID: 36940556
[TBL] [Abstract][Full Text] [Related]
75. RNA-Seq Analysis of Cisplatin and the Monofunctional Platinum(II) Complex, Phenanthriplatin, in A549 Non-Small Cell Lung Cancer and IMR90 Lung Fibroblast Cell Lines.
Monroe JD; Moolani SA; Irihamye EN; Speed JS; Gibert Y; Smith ME
Cells; 2020 Dec; 9(12):. PubMed ID: 33302475
[TBL] [Abstract][Full Text] [Related]
76. Overexpression of the transcription factor ATF3 with a regulatory molecular signature associates with the pathogenic development of colorectal cancer.
Yan F; Ying L; Li X; Qiao B; Meng Q; Yu L; Yuan X; Ren ST; Chan DW; Shi L; Ni P; Wang X; Xu D; Hu Y
Oncotarget; 2017 Jul; 8(29):47020-47036. PubMed ID: 28402947
[TBL] [Abstract][Full Text] [Related]
77. ATF3 and PRAP1 play important roles in cisplatin-induced damages in microvascular endothelial cells.
Li M; Zhai G; Gu X; Sun K
Gene; 2018 Sep; 672():93-105. PubMed ID: 29886035
[TBL] [Abstract][Full Text] [Related]
78. Transcriptome analysis upon potassium usnate exposure reveals ATF3-induced apoptosis in human gastric and colon cancer cells.
Yoo KH; Kim DH; Oh S; Park MS; Kim H; Ha HH; Cho SH; Chung IJ; Bae WK
Phytomedicine; 2021 Oct; 91():153655. PubMed ID: 34388563
[TBL] [Abstract][Full Text] [Related]
79. Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancer.
Juncheng P; Joseph A; Lafarge A; Martins I; Obrist F; Pol J; Saavedra E; Li S; Sauvat A; Cerrato G; Lévesque S; Leduc M; Kepp O; Durand S; Aprahamian F; Nirmalathansan N; Michels J; Kroemer G; Castedo M
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35772809
[TBL] [Abstract][Full Text] [Related]
80. Transcription factor ATF3 links host adaptive response to breast cancer metastasis.
Wolford CC; McConoughey SJ; Jalgaonkar SP; Leon M; Merchant AS; Dominick JL; Yin X; Chang Y; Zmuda EJ; O'Toole SA; Millar EK; Roller SL; Shapiro CL; Ostrowski MC; Sutherland RL; Hai T
J Clin Invest; 2013 Jul; 123(7):2893-906. PubMed ID: 23921126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
